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of the histopathology and histogenesisqJ. Godfrey Heathcote, MB, PhD ⇑AbstractTransitional papilloma (inverted papilloma, Schneiderian papilloma) is a relatively common, benign epithelial neoplasm of the sin-
onasal tract that also occurs in the lacrimal drainage system. The name transitional papilloma is recommended because it reflects
the key histological features required for pathological diagnosis, as well as the histogenesis of the tumour. The histogenesis of the
tumour is reviewed, together with its natural history, which is characterized by bone remodelling and destruction, a tendency to
recur and to undergo malignant transformation. Biomarkers associated with these features have been identified in the sinonasal
tumours and may also be of relevance to the lacrimal sac tumours, although the necessary studies have not yet been undertaken.
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Tumours of the lacrimal drainage system are not common
but even small ophthalmic pathology laboratories will receive
one or two each year. As in most body sites, neoplasms of the
lacrimal sac may be categorized in general as benign or
malignant, primary, secondary or metastatic and epithelial
or non-epithelial, i.e., lymphoid, melanocytic or mesenchy-
mal, and the variety of tumours is similar to that seen in the
sinonasal tract. This review will concentrate on the common-
est epithelial neoplasm of the lacrimal sac, the transitional
papilloma, its characteristic histopathology and histogenesis,
its malignant transformation and principles of management.
The recognition and diagnosis of this tumour seem to create
problems for many pathologists, in part because of the con-
fusing array of names which has been given: inverted
papilloma, inverting papilloma, squamous papilloma,
Schneiderian papilloma, transitional (cell) papilloma, amongPeer review under responsibility
of Saudi Ophthalmological Society,
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however, it is helpful to consider what is known about its
much more common counterpart in the sinonasal tract.
Sinonasal papillomas
Histopathology
A papilloma is by definition a benign neoplasm of a sur-
face epithelium. Sinonasal papillomas are conventionally clas-
sified into three morphological types:
 Fungiform (exophytic) squamous papilloma
 Cylindrical cell (oncocytic Schneiderian) papilloma
 Inverted (transitional cell) papilloma
of which the inverted papilloma is the most common
(70%).2 The adjective ‘inverted’ refers to the downwardj Production and hosting by ElsevierAccess this article online: www.saudiophthaljournal.comwww.sciencedirect.com
d 11 February 2012; available online 24 February 2012.
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underlying stroma. Although in common usage, this is an
unsatisfactory term, since the papillomas may have either
an endophytic or a combined endophytic/exophytic growth
pattern and in small biopsies the growth pattern may be hard
to recognize and the proper diagnosis may be missed. The
significance of the diagnosis stems from the propensity of
this benign tumour to recur and/or undergo malignant trans-
formation. Some authors have objected to the use of the
alternative name transitional cell papilloma, since there is
no actual ‘‘transitional cell’’.3 Nevertheless, transitional epi-
thelium is easy to recognize by light microscopy and the term
has the advantage of guiding the pathologist towards the
right diagnosis if he or she receives a small biopsy with mark-
edly thickened epithelium on its surface, even in the absence
of clearly endophytic growth. The term transitional papil-
loma, qualified by exophytic and/or endophytic, is recom-
mended by this author and will be used throughout this
article in preference to inverted papilloma or transitional cell
papilloma.
In the sinonasal tract transitional epithelium arises by
metaplasia of the normal respiratory epithelium and occurs
as an intermediate stage between the pseudostratified
columnar ciliated epithelium and stratified squamous epithe-
lium. Consequently, the epithelium has both glandular and
squamous features:
 Stratification
 No surface keratin but tonofibrils identifiable on electron
microscopy
 No intercellular bridges
 Goblet cells
 Pools of mucin (microcysts), often containing neutrophils
 A surface layer of columnar cells, possibly ciliated.
Histogenesis
Transitional metaplasia of the normal upper respiratory
tract epithelium is a frequent accompaniment of chronic
inflammation and over 20% of transitional papillomas are
associated with inflammatory nasal polyps.4 Transitional
metaplasia is the first step in the histogenesis of a papilloma
(Fig. 1a and b) and is followed by a proliferative phase in
which a hyperplastic ribbon of surface epithelium is created
(Fig. 1c). To accommodate the increasing surface area, the
epithelium begins to expand either outwards or inwards
(Fig. 1d and e), or both. Focally, the epithelium may undergo
complete squamous metaplasia with a minor amount of ker-
atinization (Fig. 1f). During development the lining mucosa of
the sinonasal tract arises from the Schneiderian membrane
which is formed by the invagination of the olfactory ecto-
derm. It is perhaps not surprising that the mucosal epithelium
should itself have an innate tendency towards endophytic
growth, although what might determine this remains unclear.
It is also unclear what factors drive the neoplastic transforma-
tion of the hyperplastic epithelium, although a role for inflam-
mation has been proposed.5
Schwerer reported an increased expression of p53 in sino-
nasal epithelium in 89% of transitional papillomas without
dysplasia and, in 35% of these, the level of expression in-
creased with transformation from respiratory-type, through
transitional to squamous epithelium.6 The proliferative
capacity of the epithelium, manifested as nuclear expressionof Ki67 in the basal and parabasal cells, also increased from
normal epithelium to papillomatous respiratory-type epithe-
lium to transitional and squamous epithelia.7
For over two decades it has been recognized that genomic
material of human papillomavirus (HPV) can be identified in
transitional papillomas. Reported detection rates have shown
considerable variation, possibly reflecting different methods
of genotype-based testing (in situ hybridization vs. polymer-
ase chain reaction with type-specific or consensus primers)
and variable quality of archival tissue specimens. In a compre-
hensive review of this topic, Lawson et al. concluded that over-
all 16% of transitional papillomas contained evidence of HPV
infection and that the ratio of low-risk (types 6/11) to high-risk
(types 16/18) HPV infection was 2.8:1.8 However, in papillo-
mas displaying high-grade dysplasia or malignant transforma-
tion the ratio of low-risk to high-risk types was reversed (1:1.1
and 1:2.4, respectively). Lawson et al. postulate that
low-risk HPV types may induce the formation of transitional
papillomas but the virus is subsequently lost from the cells;
if primary or secondary infection occurs with high-risk types,
dysplasia results with possible progression to malignancy.8Recurrence
Reported rates of recurrence of transitional papilloma are
generally between 9% and 34%, depending to some extent
on the type of surgery initially performed.4,9,10 Several authors
have reported on the association of HPV infection with recur-
rence, although others have not found this.11 Lawson et al. re-
ported the presence of HPV in 57.9% of recurrent papillomas
and Beck et al. found that the presence of HPV genomic mate-
rial in a transitional papilloma had a positive predictive value
of recurrence of 87%.8,12 Transitional papillomas that are des-
tined to recur, and the recurrent tumours, show reduced
expression of cytokeratin-14 (CK14) in the basal cells of the
epithelium, compared with normal sinonasal epithelium and
those papillomas that do not recur.13 Since this cytokeratin
is associated with the integrity of hemidesmosomes, its loss
may cause poor cell adhesion and a propensity for the seed-
ing of tumour cells during the initial surgical exploration,
resulting in subsequent recurrence. The Msx2 gene product,
which reduces the exit of cells from the cell cycle and is
localized in the basal cells of the epithelium in transitional
papilloma, may play a role in the thickening of the surface
epithelium; expression of the protein is increased in recurrent
papillomas.14 This protein also results in increased expression
of at least two bone resorption factors (TRAP, tartrate-
resistant acid phosphatase and RANKL, receptor activator
of nuclear factor-kappa B ligand) and these may contribute
to the bone remodelling that is sometimes associated with
the aggressive growth of a transitional papilloma.Malignant transformation
Although most transitional papillomas are benign, some
may undergo malignant transformation, usually to squamous
cell carcinoma or mucoepidermoid carcinoma and occasion-
ally to adenocarcinoma.1,15 Malignancy may be found within
the transitional papilloma, either as carcinoma in situ or as
a synchronous invasive carcinoma. Metachronous carcinomas
may also occur but are less common.16 In assessing the risk of
malignant transformation of a transitional papilloma, there
Figure 1. Surface epithelial changes in a recurrent transitional papilloma of the maxillary sinus. (a) Normal ciliated upper respiratory tract epithelium; (b)
metaplastic transitional epithelium with surface layer of ciliated cells; (c) thickened transitional epithelium; (d) endophytic growth of surface transitional
epithelium; (e) bland epithelium with microcysts and intra-epithelial neutrophils characteristic of transitional epithelium.
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the diagnosis of dysplasia but increased mitotic activity and
nuclear atypia within the epithelium do appear to be predic-
tive.17,18 Katori et al. demonstrated the increased expression
of epidermal growth factor receptor (EGFR) and transforming
growth factor-a (TGF-a), markers linked to the development
of squamous cell carcinoma of the head and neck, with the
transition from mild dysplasia to severe dysplasia and carci-
noma in situ, although these authors do not provide criteria
for the grading of dysplasia.18 Both EGFR and TGF-a expres-
sion were greater in transitional papillomas that expressed
HPV (types 6/11 and 16/18), as was the Ki67 index. An inverse
relation has been noted between the presence of HPV and
over-expression of p53 protein in transitional papillomas that
have undergone malignant transformation.15 In a series of 30
transitional papillomas with carcinoma, three cases with high-
risk HPV were identified and these did not over-express p53
protein. p53 protein was over-expressed in 21 of 23 tumours
lacking the evidence of HPV infection. It would appear that
infection with high-risk HPV or, perhaps more importantly,a p53 mutation leading to over-expression is associated with
malignant transformation, a conclusion in keeping with the
studies of Finkelstein et al.19
A number of other biomarkers associated with dysplasia
have been identified, including the actin cross-linking protein
fascin and matrix metalloproteinases-2 and -9.20,21 With
increasing severity of epithelial dysplasia within a papilloma,
from a moderate degree to invasive carcinoma, the expres-
sion of these two enzymes increases significantly. Since they
both have a role in the degradation of extracellular matrix,
this over-expression may be linked to the early events in
carcinogenesis and the aggressiveness of the tumour. Inter-
estingly, these authors found that the expression of HPV
types 6/11 and 16/18 was also increased with the degree of
dysplastic/malignant change.21
Orbital invasion
Because of the proximity of the sinonasal passages to the
orbit, it is not uncommon for an upper airway tumour, most
128 J.G. Heathcotefrequently a squamous cell carcinoma, to invade the orbit.22
Transitional papillomas are capable of invading the orbit and
Johnson et al. described four such patients with transitional
papillomas of the ethmoid sinus and lateral nasal wall.22 This
generally occurs because of rarefaction of the bone; papillo-
mas are not only able to infiltrate bone but may cause a variety
of radiographic changes, such as thinning, displacement and
destruction.23 In a comprehensive review of sinonasal transi-
tional papilloma, Elner et al. estimated the prevalence of orbi-
tal infiltration at 2.7%.24 These authors reviewed ten cases of
their own and found focal malignant transformation into squa-
mous cell carcinoma in six and transitional cell carcinoma in
four in the portion of the tumour within the orbit. Eight of
these patients required exenteration and three of them died
from erosion into the brain. Orbital invasion by a transitional
papilloma in the maxillary sinus may produce proptosis.25
Extension of a recurrent sinonasal transitional papilloma
through the naso-lacrimal duct into the orbit has also been de-
scribed.26 In that case areas of malignant transformation were
identified in the excised tumour but destruction of the bony
wall of the orbit was not seen.Transitional papillomas of the lacrimal sac
Histopathology and histogenesis
Given the close connections of the lacrimal drainage sys-
tem and the sinonasal tract, both embryological and anatom-
ical, it is not surprising that the same types of tumour occur in
these passages. Transitional papilloma is not only the com-
monest epithelial neoplasm in the lacrimal sac, it may co-exist
with a sinonasal transitional papilloma. This important clinical
point was recognized over 40 years ago by Harry and Ashton,
who wrote:
‘‘. . .we consider it advisable that all patients with lacrimal
sac tumours should have their respiratory passages thor-
oughly examined.’’27
Most of the morphological characteristics of sinonasal
transitional papilloma discussed earlier are shared by the lac-
rimal counterpart and careful examination of the lacrimal sac
tumours indicates that the same sequence of histogenetic
changes can be observed in papillomas at this site.
In a series of 115 lacrimal sac neoplasms collected at the
Armed Forces Institute of Pathology, Stefanyszyn et al. re-
ported 32 cases of benign papilloma, 19 squamous in type
and 13 transitional, although the authors did not indicate
the criteria used to separate these two groups.28 Patients
with squamous papillomas were slightly older than those with
transitional papillomas (mean age of 47 vs. 40 years), which
accords with the histogenetic sequence described above. In
addition, there were 6 cases of papilloma with foci of malig-
nant change in patients with a mean age of 50 years.
In their 1968 paper, in which they reported on 8 transi-
tional neoplasms of the lacrimal sac, Harry and Ashton pro-
vided useful criteria for the diagnosis of benign and
malignant tumours.27 They divided the tumours into three
categories on the basis of morphology and clinical behaviour:
Type I: Transitional papilloma
 A papillary tumour with a stratified transitional epithelium
 Marked but smooth infolding of epithelium into the stroma Uniform cytomorphology
Type II: Intermediate transitional tumour
 A papillary tumour with a stratified epithelium
 More irregular invagination of the epithelium into the
stroma
 Mild cellular pleomorphism
 Conspicuous squamous metaplasia
 Readily recognizable mitotic figures
Type III: Transitional cell carcinoma
 A neoplasm with irregular, stratified epithelium
 Invasive growth
 Marked cellular pleomorphism
 Conspicuous squamous metaplasia
 Conspicuous mitotic activity.
Harry and Ashton suggested that Type I and II lesions
could recur and both might give rise to frankly invasive carci-
nomas; however, some Type III tumours could possibly arise
de novo.27 These diagnostic criteria are of use to the practis-
ing pathologist, particularly since an initial tissue sample may
be a small biopsy obtained at dacryocystorhinostomy.29 A
diagnosis of intermediate transitional tumour in such a biopsy
should prompt consideration of a subsequent dacryocystec-
tomy to exclude a frankly invasive carcinoma, whereas, a
diagnosis of transitional papilloma might simply warrant care-
ful follow-up of the patient.
Not surprisingly HPV DNA may be identified in some tran-
sitional papillomas.30 However, detailed molecular studies of
the histogenesis have not been undertaken, in part because
of the rarity of these neoplasms, and the relationship of
HPV infection to dysplastic change has not been clarified.
As they do in the sinonasal tract, transitional papillomas in
the lacrimal sac, whether they be exophytic or endophytic,
have a propensity to recur.31,32 Although the cytomorphol-
ogy may become more atypical with recurrence, in general
recurrence does not seem to predispose to malignant trans-
formation in either the sinonasal tract or the lacrimal sac.1,2,32
Extension along the naso-lacrimal duct predisposes to recur-
rence and the benign tumour may also extend into the nose
and/or orbit by erosion of the bone of the lacrimal fossa as it
grows (Fig. 2).
Malignant transformation
In addition to the six carcinomas arising in papillomas of
the sac, Stefanyszyn et al. identified 38 carcinomas arising
de novo.28 Squamous cell carcinoma was the commonest
malignancy (22/38) and transitional cell carcinoma (5/38)
the second commonest. The mean age at diagnosis for squa-
mous cell carcinoma was 63 years, considerably higher than
that for transitional cell carcinoma (47 years). Ni et al.
found 6 transitional cell carcinomas among 40 lacrimal sac
carcinomas.33 Other reports of cases of transitional cell carci-
noma have been published, arising both in transitional papil-
loma and de novo.34–36 Parmar and Rose described two cases
of invasive transitional cell carcinoma, one with some squa-
mous differentiation and the other with an admixed compo-
nent of squamous cell carcinoma.37 Fliss et al. reported two
cases of mucoepidermoid carcinoma of the lacrimal sac that
Figure 2. A man with a 12 month history of a lump in the left medial canthus and epiphora. (a) CT scan showing apparent invasion of orbit by mass in left
lacrimal fossa, interpreted as malignant by radiologist; (b) dacryocystectomy specimen: sac lumen obliterated by papilloma with ‘ribbon’ of thickened
epithelium; (c) transitional papilloma with mixed exophytic and endophytic growth pattern [haematoxylin & eosin]; (d) residual fragments of bone of
lacrimal fossa on outer surface of sac stained black with von Kossa reagent.
Figure 3. Transitional cell carcinoma of lacrimal sac. (a) CT scan showing mass in right medial canthus; (b) circumscribed nests of atypical transitional
epithelium in biopsy of mass; (c) surface origin of invasive transitional cell carcinoma in dacryocystectomy specimen [haematoxylin & eosin].
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these cases the invasive carcinoma was in continuity with a
predominantly exophytic transitional papilloma.38 These
observations support the concept that transitional metaplasia
precedes squamous differentiation and that neoplasms
arising from the surface epithelium of the sac do so from
transitional epithelium.
Persistent epiphora and a medial canthal mass, generally
above but sometimes below the medial canthal tendon, is
the classical presentation of a tumour of the lacrimal sac
and the presence of pain and blood-stained tears is a strong
indicator of malignancy. Transitional cell carcinoma is the sec-
ond commonest carcinoma arising de novo in the lacrimal
sac, after squamous cell carcinoma.28 However, as with the
corresponding papillomas, the light microscopic differentia-
tion of a transitional cell carcinoma from a non-keratinizing
squamous cell carcinoma is subjective and squamous meta-
plasia is seen in some transitional carcinomas.27 As indicated
above, the presence of atypical transitional epithelium with-
out definite stromal invasion, should lead to a diagnosis of
intermediate transitional tumour and further surgery. In the
case illustrated in Fig. 3 a patient with a clinical picture sug-
gestive of a malignant sac neoplasm was given a diagnosis
of intermediate transitional tumour on biopsy but the re-
sected specimen showed clearly invasive growth with peri-
neural infiltration and extension along the naso-lacrimal
duct. This patient was not given post-operative radiotherapy,
although it has been recommended for the patients with
incompletely excised tumours and for those who find radical
surgery unacceptable.34,39 Firm information on the prognosis
of these carcinomas is difficult to obtain because of their rar-
ity. Metastases to regional nodes, lungs, oesophagus, liver
and skeleton have been described but patients who die of
tumour usually do so because of local recurrence.33,39
Conclusion
Transitional papillomas of the sinonasal tract and lacrimal
sac have identical histopathological appearances and histo-
genetic pathways. They also appear to have a similar natural
history and the two tumours may co-exist in the same patient,
although sac tumours are much less common. The pathoge-
netic mechanisms underlying the development and behav-
iour of sinonasal transitional papillomas are being
elucidated but, apart from a possible role of HPV, these have
not been studied in sac papillomas.
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